Salvage Treatment with Cefiderocol Regimens in Two Intravascular Foreign Body Infections by MDR Gram-Negative Pathogens, Involving Non-Removable Devices.
Cefiderocol
Foreign body infections
Gram-negative bacteria
Multidrug resistance
Journal
Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
accepted:
09
12
2020
pubmed:
9
1
2021
medline:
9
1
2021
entrez:
8
1
2021
Statut:
ppublish
Résumé
The objective of this study was to describe two challenging cases of intravascular foreign body infections caused by multidrug-resistant Gram-negative pathogens requiring complex antimicrobial regimens including cefiderocol and successfully treated without implant removal. Clinical charts and microbiological reports of the clinical cases. Case 1 included a left ventricular assist device (HEARTMATE 3™Abbot Cefiderocol may be an additional, promising drug to the available arsenal, even for challenging foreign body infections caused by MDR Gram-negative pathogens.
Identifiants
pubmed: 33417231
doi: 10.1007/s40121-020-00385-4
pii: 10.1007/s40121-020-00385-4
pmc: PMC7955010
doi:
Types de publication
Journal Article
Langues
eng
Pagination
575-581Références
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Int J Antimicrob Agents. 2019 Apr;53(4):456-466
pubmed: 30471402
Clin Infect Dis. 2019 May 17;68(11):1932-1934
pubmed: 30418554
Int J Antimicrob Agents. 2019 Feb;53(2):177-184
pubmed: 30395986
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7396-7401
pubmed: 27736756
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S544-S551
pubmed: 31724049
J Antimicrob Chemother. 2017 Jun 1;72(6):1704-1708
pubmed: 28369471
J Antimicrob Chemother. 2019 Nov 1;74(11):3399-3401
pubmed: 31369095
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30323050
Lancet Infect Dis. 2018 Dec;18(12):1319-1328
pubmed: 30509675
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29158270
Eur J Clin Pharmacol. 2015 Jul;71(7):801-10
pubmed: 26008213
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28848004
Drugs. 2019 Feb;79(3):271-289
pubmed: 30712199
Lancet Infect Dis. 2021 Feb;21(2):213-225
pubmed: 33058798